FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements

FDA announces addition of Dietary Supplement Ingredient Advisory List page to its website to identify ingredients it has preliminary determined should be used in dietary supplements. It also publishes warning letters submitted recently to firms marketing supplements containing two ingredients agency has concluded should not be used: eight were warned about using an ingredient identified as "DMHA" and three about using phenibut.

The US Food and Drug Administration delivers on its plan for a "rapid response tool" to identify and publish ingredients the agency says could be ineligible for use in dietary supplements. The tool doesn't, however, deliver brand names or identify firms marketing products containing the ingredients.

The FDA announced the addition of the Dietary Supplement Ingredient Advisory List to its website on April 16 with four ingredients – andarine, higenamine, hordenine and 1,4-DMAA– that the agency has preliminarily determined should not be used vitamin, minerla or supplement products because they are not dietary ingredients or are new dietary ingredients that have not been notified to the agency with proof of a reasonable expectation of safety for their intended use

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation